KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Non-Current Assets (2016 - 2026)

AbbVie has reported Non-Current Assets over the past 14 years, most recently at $104.9 billion for Q4 2025.

  • Quarterly Non-Current Assets fell 4.27% to $104.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $426.7 billion through Dec 2025, down 3.76% year-over-year, with the annual reading at $104.9 billion for FY2025, 4.27% down from the prior year.
  • Non-Current Assets was $104.9 billion for Q4 2025 at AbbVie, roughly flat from $105.4 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $123.9 billion in Q1 2021 and troughed at $101.7 billion in Q4 2023.
  • The 5-year median for Non-Current Assets is $109.8 billion (2024), against an average of $111.3 billion.
  • Year-over-year, Non-Current Assets surged 214.22% in 2021 and then decreased 8.89% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $118.6 billion in 2021, then dropped by 6.96% to $110.3 billion in 2022, then decreased by 7.82% to $101.7 billion in 2023, then increased by 7.74% to $109.6 billion in 2024, then decreased by 4.27% to $104.9 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Non-Current Assets are $104.9 billion (Q4 2025), $105.4 billion (Q3 2025), and $107.9 billion (Q2 2025).